AuroraPrime RMA (Regulatory & Medical Authoring): AI-Orchestrated Authoring and QC Across the R&D Document Network

AuroraPrime RMA (Regulatory & Medical Authoring): AI-Orchestrated Authoring and QC Across the R&D Document Network

Information

AlphaLife Sciences’ flagship platform, AuroraPrime RMA, streamlines end-to-end regulatory and medical writing through AI-driven orchestration, source-linked drafting, and embedded quality control.

This demo showcases automated CSR generation from protocols and SAP, real-time section drafting, and version-controlled quality workflows. It highlights key message–driven authoring aligned with scientific and regulatory positioning, as well as support for non-clinical (M2.6) and CMC workflows through AI-enabled templates, intelligent document mapping, and automated data population. Dependency visualization, batch generation, and AI-assisted editing enable faster, traceable, and compliant authoring across the R&D document network.

AlphaLife SciencesD10About Company The AlphaLife Sciences team is uniquely positioned to lead this category, combining world-class engineering talent—over 80% from Google, Verily, Microsoft, and Veeva—with deep domain expertise in pharma, regulatory writing, and clinical development. Our technical leadership is validated by formal selection into the technology programs of Microsoft, Google, NVIDIA, Veeva, and JLABS, as well as our role as Microsoft’s strategic AI content authoring partner for life sciences. This foundation enables the rapid, production-grade deployment of advanced AI—including RAG, agentic AI, and multi-agent systems—within a rigorously engineered, compliant platform already adopted by more than half of the global top-20 pharmaceutical companies. Backed by an advisory network that includes the former head of new drug review at the FDA, along with senior leaders from major pharma companies, CROs, and specialized life-sciences consultancies, the team consistently delivers enterprise-scale, regulatory-grade impact. Vision, Mission, and Key Pillar Products Our Vision is to accelerate global drug development—making it faster and more affordable through AI. Our Mission is to automate life-science content authoring and insight generation with AI, enabling biopharma teams to achieve greater efficiency, quality, and compliance. Our four pillar product lines, in both production and roadmap, are delivered through the AuroraPrime suite—a scalable, hyperscaler-powered GenAI platform built on Content Authoring, Content Insights, an AI Platform for Developers, and 360° Clinical Efficiency—together enabling true end-to-end drug lifecycle transformation.